Gujarat Themis Biosyn Ltd
BSE:506879
Gujarat Themis Biosyn Ltd
BSE:506879
Price:
400.15 INR
0.41%
Market Closed
Updated:
May 13, 2024
Gujarat Themis Biosyn Ltd
Interest Income Expense
|
Gujarat Themis Biosyn Ltd
Interest Income Expense Peer Comparison
Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Gujarat Themis Biosyn Ltd
BSE:506879
|
Interest Income Expense
-₹1.8m
|
CAGR 3-Years
43%
|
CAGR 5-Years
6%
|
CAGR 10-Years
12%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Interest Income Expense
-₹1.3B
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Interest Income Expense
-₹1.1B
|
CAGR 3-Years
17%
|
CAGR 5-Years
8%
|
CAGR 10-Years
2%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Interest Income Expense
-₹1.9B
|
CAGR 3-Years
11%
|
CAGR 5-Years
25%
|
CAGR 10-Years
-15%
|
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Interest Income Expense
₹2.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Interest Income Expense
-₹3.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-23%
|
See Also
What is Gujarat Themis Biosyn Ltd's Interest Income Expense?
Interest Income Expense
-1.8m
INR
-1.8m
INR
Based on the financial report for Dec 31, 2023, Gujarat Themis Biosyn Ltd's Interest Income Expense amounts to -1.8m INR.
What is Gujarat Themis Biosyn Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
12%
12%
Over the last year, the Interest Income Expense growth was 49%. The average annual Interest Income Expense growth rates for Gujarat Themis Biosyn Ltd have been 43% over the past three years , 6% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
